Overexpression of IL-17A was ascertained by both immunohistochemistry and western blot analysis, which showed a 2.5-fold increase in the value obtained in no-psoriatic myocarditis and a six-fold increase in the normal myocardial controls. This evidence concerns the gene IL17A and myocarditis.